SNCA and Parkinson disease: The Systemic Synuclein Sampling Study (S4) demonstrated the feasibility and relative safety of obtaining multiple peripheral tissues—skin, colon, and submandibular gland—alongside biofluids for αSyn analysis in PD patients [13].